News & Events
View recent news and events relating to research at Providence Health Care.
Subscribe to our weekly newsletters here to keep updated with the latest news and events from Providence Research.
Cheyenne Johnson has been appointed Executive Director of the BC Centre on Substance Use (BCCSU), housed within Providence Health Care.
Ms. Johnson was selected following a recruitment process led by Providence Health Care Research Institute (PHCRI), after previously acting as interim executive director of BCCSU.
Research has found that a single dose of the Pfizer-BioNTech COVID-19 vaccine produces a much weaker antibody response in long-term care residents than it does in younger healthy adults.
Reema Garcha successfully donated a kidney to her sister Binn Johal, but their experience is not always the case within the South Asian community.
The transition from academic life to the working world highlighted the importance of certain skills that aren’t generally taught in school, Kimia Shahangian, a Scientific Marketing Specialist at STEMCELL Technologies, says.
As a Scientist at the Centre for Health Evaluation and Outcome Sciences (CHÉOS), plus the FLEX Site Co-Director for the Vancouver-Fraser Medical Program, Dr. Amy Salmon was dealing with the pandemic on all levels at work.
And then she got COVID-19.
For Jenny Bailey, volunteering to participate in the study was an easy decision that she says she made for the sake of humanity. The 95-year-old, who has been living at Brock Fahrni for five years, received his first dose of the COVID-19 vaccine in early January and says he hopes his participation in the research study will help protect others.
The federal government announced more than $15 million for four community-based safer drug supply projects in B.C. this week in response to the ongoing overdose crisis, which has been worsened by the COVID-19 pandemic.
Practising self-care, taking time to grieve, learning more about the palliative approach – these are all strategies researchers have identified to help long-term care staff cope with death.
A pilot study has shown that an experimental vaccine can reduce the systemic immune response and symptoms of allergic rhinitis in individuals allergic to cats, including nasal congestion, sneezing, nasal itching and runny nose.
Congratulations to Dr. Anita Palepu for winning the 2020 Research and Mission Award. This annual award recognizes a scientist in our organization who demonstrates the mission and values of Providence Health Care while conducting outstanding research.
The Canada Research Continuity Emergency Fund (CRCEF) is a Tri-Agency program that is part of the Government of Canada's COVID-19 economic response plan. UBC is currently taking application for Stage 3 which supports maintenance and ramp-up costs incurred due to COVID-19.
As the COVID-19 pandemic wears on, it has become clear that different age groups are experiencing the social and economic consequences of the virus in different ways.
Providence researchers are lending their research expertise and diagnostic know-how to support the WestJet-YVR COVID-19 Testing Study, a project sponsored by WestJet and Vancouver Airport Authority (YVR).
Please join the Providence Health Care Research Institute (PHCRI) for a virtual Town Hall event. Our President, Dr. Darryl Knight, will reflect on the challenges and accomplishments from a year that has been unlike any other.
Atrial fibrillation patients do better with surgical procedure than drugs as initial treatment: study
New research led by a St. Paul’s Hospital cardiologist has found that a minimally invasive procedure provides longer-lasting benefits than drugs as the first course of treatment for this common heart condition.
A new study has found that rotating the swab after it’s inserted into the nose – a step that makes the procedure take longer, and may increase patient discomfort – does not improve the quality of the sample collected and is therefore unnecessary.
A global pioneer in the treatment of HIV/AIDS is being recognized for his groundbreaking contributions to medicine with a commemorative postage stamp.
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
From being asymptomatic to developing life-threatening symptoms, it’s become clear that people infected with COVID-19 respond to the virus with vastly different degrees of severity.
A recent study shows that some people may still be able to hear while in an unresponsive state at the end of their life.